BridgeBio Pharma Director Charles Homcy Sells 788 Shares for Tax Obligation

This Form 4 filing reports that Charles J. Homcy, a director of BridgeBio Pharma, Inc. (BBIO), sold 788 shares of common stock on June 20, 2026. The shares were sold at $66.27 per share, resulting in total proceeds of approximately $52,220. The transaction was coded as "F" (tax withholding) and "D" (disposed), with the shares being withheld to satisfy Homcy's tax obligations related to the vesting of 2,196 restricted stock units (RSUs). Following this transaction, Homcy still holds 915,886 shares of BridgeBio Pharma common stock. The filing was signed by attorney-in-fact Will Solis on June 23, 2026, and the transaction was reported as a routine tax withholding event rather than a discretionary sale.